TTM
$57M
YoY change
+48.3%
5Y CAGR
+52.1%
Peak year (FY2025)
$62.4M
Cumulative revenue
$235M
Revenue history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: $62.4M
Revenue growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +48.3%
Revenue history table for Tango Therapeutics (TNGX) from 2019 to 2025
| FY2025 | $62.4M | +48.3% | +$20.3M | ||
| FY2024 | $42.1M | +15.2% | +$5.54M | ||
| FY2023 | $36.5M | +46.9% | +$11.7M | ||
| FY2022 | $24.9M | -32.9% | -$12.2M | ||
| FY2021 | $37M | +383.8% | +$29.4M | ||
| FY2020 | $7.66M | -68.9% | -$17M | ||
| FY2019 | $24.6M | — | — |
- FY2025$62.4M+48.3%
- FY2024$42.1M+15.2%
- FY2023$36.5M+46.9%
- FY2022$24.9M-32.9%
- FY2021$37M+383.8%
- FY2020$7.66M-68.9%
- FY2019$24.6M—
Revenue values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's current revenue (TTM) is $57M. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for Tango Therapeutics (TNGX) came in at $62.4M – surged 48.3% year-over-year.
Tango Therapeutics revenue compound annual growth for the 2020–2025 (5 years) window is +52.1%, sustaining 3 straight years of year-over-year growth.
2025 marks the peak revenue at $62.4M, with the historical low of $7.66M recorded in 2020.
Tango Therapeutics Revenue by Year
Tango Therapeutics Revenue 2025: $62.4M
In 2025, Tango Therapeutics reported revenue of $62.4M, surged 48.3% from 2024. This figure represents the highest annual value in the available history.
Tango Therapeutics Revenue 2024: $42.1M
Tango Therapeutics revenue in 2024 was $42.1M, grew 15.2% from 2023.
Tango Therapeutics Revenue 2023: $36.5M
2023's revenue for Tango Therapeutics came in at $36.5M, surged 46.9% from 2022.
Tango Therapeutics Revenue 2022: $24.9M
Tango Therapeutics posted revenue of $24.9M in 2022, plunged 32.9% below 2021.
Tango Therapeutics Revenue 2021: $37M
Tango Therapeutics revenue in 2021 was $37M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Revenue
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $64.9B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $36.7B |
- $94.2B
- $65.2B
- $64.9B
- $61.2B
- $48.2B
- $36.7B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.